SCHEMBL5887248

SCHEMBL5887248

COc1ccc(OC(F)(F)F)c2cc(-c3[c]cccc3)oc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
CYP3A4 P08684 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ADRA2A P08913 3/20 0.35
ADRA2B P18089 3/20 0.35
ADRA2C P18825 3/20 0.35
F2RL3 Q96RI0 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
PDE10A Q9Y233 1/20 0.33
CYP1A1 P04798 3/20 0.33
CYP1A2 P05177 3/20 0.33
CYP1B1 Q16678 3/20 0.33
RPS6KA2 Q15349 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4007835 0.68 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EF2RL3NPC1
SCHEMBL5322053 0.66 ALDH1A1 (0.43) ALDH1A1CYP3A4MAPTKDM4EL3MBTL1
SCHEMBL13233407 0.65 ESR1 (0.55) ALDH1A1HPGDCYP3A4MAPTF2RL3
SCHEMBL5326185 0.65 AR (0.43)
SCHEMBL18133386 0.64 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL1558708 0.63 CA1 (0.46) ALDH1A1HPGDCYP3A4MAPTKDM4E
SCHEMBL3223322 0.63 CYP1A2 (0.41) ALDH1A1HPGDCYP3A4MAPTKDM4E
SCHEMBL5322067 0.63 PDE4A (0.50) ALDH1A1HPGDCYP3A4MAPTKDM4E
SCHEMBL5326536 0.62 ERN1 (0.40) ALDH1A1HPGDMAPTKDM4EHSD17B10
SCHEMBL5321545 0.62 PTGS2 (0.46) ALDH1A1HPGDMAPTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed
JP-2006501194-A 2006-01-12 JP claimed
EP-1525190-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-04-27 EP claimed
WO-2004007463-A1 CCK-1 RECEPTOR MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-01-22 WO claimed